![Prasanna Balaprakash](/sites/default/files/styles/featured_square_large/public/2024-08/2023-P02525.jpg?h=502e75fa&itok=ePVQC-A5)
Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (48)
- (-) Biomedical (29)
- 3-D Printing/Advanced Manufacturing (42)
- Advanced Reactors (8)
- Big Data (27)
- Bioenergy (51)
- Biology (60)
- Biotechnology (12)
- Buildings (20)
- Chemical Sciences (26)
- Clean Water (14)
- Climate Change (50)
- Composites (8)
- Computer Science (87)
- Coronavirus (17)
- Critical Materials (4)
- Cybersecurity (14)
- Decarbonization (46)
- Education (1)
- Emergency (2)
- Energy Storage (29)
- Environment (104)
- Exascale Computing (27)
- Fossil Energy (4)
- Frontier (25)
- Fusion (31)
- Grid (25)
- High-Performance Computing (45)
- Hydropower (5)
- Isotopes (27)
- ITER (2)
- Machine Learning (22)
- Materials (43)
- Materials Science (46)
- Mathematics (7)
- Mercury (7)
- Microelectronics (2)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (39)
- Net Zero (8)
- Neutron Science (47)
- Nuclear Energy (55)
- Partnerships (19)
- Physics (30)
- Polymers (8)
- Quantum Computing (21)
- Quantum Science (30)
- Renewable Energy (1)
- Security (11)
- Simulation (32)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (31)
- Sustainable Energy (47)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![Blue sky above ORNL campus.](/sites/default/files/styles/list_page_thumbnail/public/2020-11/ORNLCampus1_0.jpg?h=85f71c8f&itok=Bic6TXC0)
ORNL and three partnering institutions have received $4.2 million over three years to apply artificial intelligence to the advancement of complex systems in which human decision making could be enhanced via technology.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
![Enzyme activity during organophosphate poisoning](/sites/default/files/styles/list_page_thumbnail/public/2020-08/anecdote1_0.png?h=d1cb525d&itok=wpYYilBI)
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
![Computational biophysicist Ada Sedova is using experiments and high-performance computing to explore the properties of biological systems and predict their form and function, including research to accelerate drug discovery for COVID-19. Photo credit: Jason Richards, Oak Ridge National Laboratory, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2020-07/2017-P06162Cropped.jpg?h=f1d4573a&itok=TrvR_opt)
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
![Omar Demerdash](/sites/default/files/styles/list_page_thumbnail/public/2020-05/demerdash_crop.jpg?h=8831409f&itok=2J2gUqDr)
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
![Coronavirus graphic](/sites/default/files/styles/list_page_thumbnail/public/2020-04/covid19_jh_0.png?h=d1cb525d&itok=PyngFUZw)
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
![Scientists created a novel polymer that is as effective as natural proteins in transporting protons through a membrane. Credit: ORNL/Jill Hemman](/sites/default/files/styles/list_page_thumbnail/public/2020-03/19-G01195_nature_feature_0.png?h=e4fbc3eb&itok=K8czXmTr)
Biological membranes, such as the “walls” of most types of living cells, primarily consist of a double layer of lipids, or “lipid bilayer,” that forms the structure, and a variety of embedded and attached proteins with highly specialized functions, including proteins that rapidly and selectively transport ions and molecules in and out of the cell.